@article{article, title  = {{A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy}},

 publisher = {{Wiley}},

 url = {{https://eprints.whiterose.ac.uk/177102/ }},

 year = {{2021}},

 month = {{2}},

 author = {{Paller AS and Siegfried EC and Simpson EL and Cork MJ and Lockshin B and Kosloski MP and Kamal MA and Davis JD and Sun X and Pirozzi G and Graham NMH et al}},

 doi = {{10.1111/jdv.16928}},

 volume = {{35}},

 journal = {{Journal of the European Academy of Dermatology and Venereology}},

 issue = {{2}},

 pages = {{464-475}},

 note = {{Accessed on 2024/12/22}}}